Coronavirus, COVID, Ethics, Research

Mixed Lessons from Intentionally Infecting People with Covid-19

The idea sounded counterintuitive, but by carefully dosing individuals with SARS-CoV-2 in a controlled setting, scientists could study how the virus affects the body and learn what factors may offer protective benefits.

These types of studies, called human challenge trials, could help fast-track understanding the deadly virus devastating the world, experts claimed. Others, though, questioned whether the potential benefits were worth the risk, particularly given the host of unknowns surrounding Covid-19, and the lack of available treatments at the time.

Drugs, Mental Health, Research

Hallucinogens approved for treating psychiatric disorders: what does the science say?

Hallucinogens are now being presented as a breakthrough in the treatment of severe psychiatric disorders, such as depression or post-traumatic stress disorder, sometimes in combination with psychotherapy).

Despite being presented as innovations, the therapeutic potential of psychedelics is not a new discovery. In the 1960s and 70s, these substances were explored for medical use but quickly fell out of favour due to regulatory restrictions.

Now, in 2024, the question remains: Are psychedelics genuinely effective for treating psychiatric disorders?

Picture of a white rat in a researcher's gloved hand.
Ethics, Research

What is ethical animal research? A scientist and veterinarian explain

Federal research agencies follow guiding principles in evaluating the use and care of animals in research.These principles are summarized by the “3 R’s” of animal research: reduction, refinement and replacement. The 3 R’s encourage scientists to develop new techniques that allow them to replace animals with appropriate alternatives.

Immunology, Research, Transplantation

The journey to a pig-heart transplant began 60 years ago

On Friday, January 7 2022, David Bennett became the world’s first person to successfully receive a transplant of a pig’s heart. The eight-hour-long operation by surgeons at the University of Maryland Medical Center in Baltimore, USA, was no doubt arduous. But it was a short final step in a 60-year-long journey to genetically alter the pig’s heart so that it would not be immediately rejected – a journey that began with a plane crash in Oxford in the summer of 1940.